Beta-blocking effect of propafenone based on spectral analysis of heart rate variability

Federico Lombardi, Daniela Torzillo, Giulia Sandrone, Laura Dalla Vecchia, Maria Luisa Finocchiaro, Roberto Bernasconi, Emanuele Cappiello

Research output: Contribution to journalArticle

Abstract

RR variability was analyzed in 15 patients with ventricular arrhythmias to evaluate whether the antiarrhythmic action of propafenone is associated with alteration of neural control mechanisms. Before drug administration, spectral analysis of RR variability was characterized by 2 major components at low and high frequency, which are considered to reflect sympathetic and parasympathetic modulation of the heart period. After propafenone (600 to 900 mg/day), there was a marked reduction in RR variance (826 ± 184 to 412 ± 77 ms2; p <0.05), although the mean RR interval was unchanged. The drug significantly reduced the low-frequency component (52 ± 6 to 28 ± 4 nu) and augmented the high-frequency component (39 ± 6 to 55 ± 5 nu). As a result, the low-/high-frequency ratio (an index of sympathovagal balance) decreased from 2.0 ± 0.4 to 0.6 ± 0.1. A positive correlation between serum levels and drug-induced changes in the low-frequency component was also observed. Furthermore, the increase in the low-frequency component induced by tilt (53 ±5 to 79 ± 3 nu) was markedly attenuated after drug administration (27 ± 5 to 54 ± 7 nu). Thus, propafenone administration is associated with changes in spectral components that are consistent with a β-blocking effect of the drug.

Original languageEnglish
Pages (from-to)1028-1034
Number of pages7
JournalThe American Journal of Cardiology
Volume70
Issue number11
DOIs
Publication statusPublished - Oct 15 1992

Fingerprint

Propafenone
Heart Rate
Pharmaceutical Preparations
Cardiac Arrhythmias
Serum

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Beta-blocking effect of propafenone based on spectral analysis of heart rate variability. / Lombardi, Federico; Torzillo, Daniela; Sandrone, Giulia; Vecchia, Laura Dalla; Finocchiaro, Maria Luisa; Bernasconi, Roberto; Cappiello, Emanuele.

In: The American Journal of Cardiology, Vol. 70, No. 11, 15.10.1992, p. 1028-1034.

Research output: Contribution to journalArticle

Lombardi, Federico ; Torzillo, Daniela ; Sandrone, Giulia ; Vecchia, Laura Dalla ; Finocchiaro, Maria Luisa ; Bernasconi, Roberto ; Cappiello, Emanuele. / Beta-blocking effect of propafenone based on spectral analysis of heart rate variability. In: The American Journal of Cardiology. 1992 ; Vol. 70, No. 11. pp. 1028-1034.
@article{de66410bb03a4cd3b8a9f5f13fb18005,
title = "Beta-blocking effect of propafenone based on spectral analysis of heart rate variability",
abstract = "RR variability was analyzed in 15 patients with ventricular arrhythmias to evaluate whether the antiarrhythmic action of propafenone is associated with alteration of neural control mechanisms. Before drug administration, spectral analysis of RR variability was characterized by 2 major components at low and high frequency, which are considered to reflect sympathetic and parasympathetic modulation of the heart period. After propafenone (600 to 900 mg/day), there was a marked reduction in RR variance (826 ± 184 to 412 ± 77 ms2; p <0.05), although the mean RR interval was unchanged. The drug significantly reduced the low-frequency component (52 ± 6 to 28 ± 4 nu) and augmented the high-frequency component (39 ± 6 to 55 ± 5 nu). As a result, the low-/high-frequency ratio (an index of sympathovagal balance) decreased from 2.0 ± 0.4 to 0.6 ± 0.1. A positive correlation between serum levels and drug-induced changes in the low-frequency component was also observed. Furthermore, the increase in the low-frequency component induced by tilt (53 ±5 to 79 ± 3 nu) was markedly attenuated after drug administration (27 ± 5 to 54 ± 7 nu). Thus, propafenone administration is associated with changes in spectral components that are consistent with a β-blocking effect of the drug.",
author = "Federico Lombardi and Daniela Torzillo and Giulia Sandrone and Vecchia, {Laura Dalla} and Finocchiaro, {Maria Luisa} and Roberto Bernasconi and Emanuele Cappiello",
year = "1992",
month = "10",
day = "15",
doi = "10.1016/0002-9149(92)90355-3",
language = "English",
volume = "70",
pages = "1028--1034",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Beta-blocking effect of propafenone based on spectral analysis of heart rate variability

AU - Lombardi, Federico

AU - Torzillo, Daniela

AU - Sandrone, Giulia

AU - Vecchia, Laura Dalla

AU - Finocchiaro, Maria Luisa

AU - Bernasconi, Roberto

AU - Cappiello, Emanuele

PY - 1992/10/15

Y1 - 1992/10/15

N2 - RR variability was analyzed in 15 patients with ventricular arrhythmias to evaluate whether the antiarrhythmic action of propafenone is associated with alteration of neural control mechanisms. Before drug administration, spectral analysis of RR variability was characterized by 2 major components at low and high frequency, which are considered to reflect sympathetic and parasympathetic modulation of the heart period. After propafenone (600 to 900 mg/day), there was a marked reduction in RR variance (826 ± 184 to 412 ± 77 ms2; p <0.05), although the mean RR interval was unchanged. The drug significantly reduced the low-frequency component (52 ± 6 to 28 ± 4 nu) and augmented the high-frequency component (39 ± 6 to 55 ± 5 nu). As a result, the low-/high-frequency ratio (an index of sympathovagal balance) decreased from 2.0 ± 0.4 to 0.6 ± 0.1. A positive correlation between serum levels and drug-induced changes in the low-frequency component was also observed. Furthermore, the increase in the low-frequency component induced by tilt (53 ±5 to 79 ± 3 nu) was markedly attenuated after drug administration (27 ± 5 to 54 ± 7 nu). Thus, propafenone administration is associated with changes in spectral components that are consistent with a β-blocking effect of the drug.

AB - RR variability was analyzed in 15 patients with ventricular arrhythmias to evaluate whether the antiarrhythmic action of propafenone is associated with alteration of neural control mechanisms. Before drug administration, spectral analysis of RR variability was characterized by 2 major components at low and high frequency, which are considered to reflect sympathetic and parasympathetic modulation of the heart period. After propafenone (600 to 900 mg/day), there was a marked reduction in RR variance (826 ± 184 to 412 ± 77 ms2; p <0.05), although the mean RR interval was unchanged. The drug significantly reduced the low-frequency component (52 ± 6 to 28 ± 4 nu) and augmented the high-frequency component (39 ± 6 to 55 ± 5 nu). As a result, the low-/high-frequency ratio (an index of sympathovagal balance) decreased from 2.0 ± 0.4 to 0.6 ± 0.1. A positive correlation between serum levels and drug-induced changes in the low-frequency component was also observed. Furthermore, the increase in the low-frequency component induced by tilt (53 ±5 to 79 ± 3 nu) was markedly attenuated after drug administration (27 ± 5 to 54 ± 7 nu). Thus, propafenone administration is associated with changes in spectral components that are consistent with a β-blocking effect of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0026726436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026726436&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(92)90355-3

DO - 10.1016/0002-9149(92)90355-3

M3 - Article

C2 - 1357951

AN - SCOPUS:0026726436

VL - 70

SP - 1028

EP - 1034

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 11

ER -